2025-03-12 12:53:54
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Suven Life Sciences posts Q4FY22 consolidated loss of Rs. 20.79 crores
Posted On : 2022-05-07 14:33:18( TIMEZONE : IST )
Suven Life Sciences Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 4.3395 crores during the period ended March 31, 2022 as compared to Rs. 4.5738 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. -20.7981 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. -33.6903 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. -1.63 for the period ended March 31, 2022 as compared to Rs. -2.65 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 4.3395 crs | ₹4.5738 crs |  -5.12% |
| Net Profit | ₹-20.7981 crs | ₹-33.6903 crs |  38.27% |
| EPS | ₹-1.63 | ₹-2.65 | 38.49% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 4.3395 crores during the period ended March 31, 2022 as compared to Rs.2.8802 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-20.7981 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.-21.6124 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.-1.63 for the period ended March 31, 2022 as compared to Rs.-1.70 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 4.3395 crs | ₹2.8802 crs |  50.67% |
| Net Profit | ₹-20.7981 crs | ₹-21.6124 crs | 3.77% |
| EPS | ₹-1.63 | ₹-1.70 | 4.12% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.17.1614 crores during the Financial Year ended March 31, 2022 as compared to Rs.21.2320 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-121.9951 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.-72.1512 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.-9.57 for the Financial Year ended March 31, 2022 as compared to Rs.-5.67 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹17.1614 crs | ₹21.2320 crs | -19.17% |
| Net Profit | ₹-121.9951 crs | ₹-72.1512 crs |  69.08% |
| EPS | ₹-9.57 | ₹-5.67 | 68.78% |
Shares of Suven Life Sciences Limited was last trading in BSE at Rs. 82.30 as compared to the previous close of Rs. 84.10. The total number of shares traded during the day was 38950 in over 773 trades.
The stock hit an intraday high of Rs. 83.90 and intraday low of 81.55. The net turnover during the day was Rs. 3223881.00.
